RBP4 and myeloid sarcoma: Subjects with persistent MS had higher RBP4 levels at baseline than those with baseline MS only (RBP4, 41.94 ± 10.00 μg/ml vs. 34.33 ± 10.15 μg/ml, P = 0.010 after adjustment for the same confounding variables).